Position in SCLX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$5,327
-$4,432 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $16,087,471,930 across 16 Drug Manufacturers - General names. SCLX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,435,647 | $3,528,649,542 | |
| 2 | LLY |
ELI LILLY & Co
|
3,547,772 | $3,263,134,246 | |
| 3 | AZN |
Astrazeneca PLC
|
12,129,724 | $2,392,224,162 | |
| 4 | ABBV |
AbbVie Inc.
|
9,531,362 | $2,072,975,912 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,540,774 | $1,508,529,698 | |
| 6 | PFE |
Pfizer Inc
|
31,428,987 | $882,525,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,222,328 | $867,205,844 | |
| 8 | AMGN |
Amgen Inc
|
2,255,759 | $793,688,795 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,327 | 800 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $9,759 | 800 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $15,743 | 800 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,712 | 800 | Shares | Defined | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||